Insmed's Series C - II Round

Insmed raised a round of funding on April 01, 2000.

Insmed is a biopharmaceutical company dedicated to improving the lives of patients battling serious rare diseases. Insmed is focused on the development and commercialization of ARIKAYCE, or liposomal …

Articles about Insmed's Series C - II Round: